← Eichor
Study identifier: NCT06624098 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma

Condition: Advanced Hepatocellular Carcinoma · Variceal Bleeding  ·  Sponsor: Sun Yat-sen University

PhaseNA
Planned participants22
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Hepatocellular carcinoma (HCC) with main trunk portal vein tumor thrombus (PVTT) has poor prognosis. The main lethiferous factor is the upper gastrointestinal hemorrhage by PVTT-related portal hypertension. Studies have proven that early transjugular intrahepatic portosystemic shunt (TIPS) with 72 hours after acute variceal bleeding is effective.

This description comes directly from the study's public registry record.

Talk to the study team

Qunfang Zhou, MD  ·  86 19868000115  ·  zhouqun988509@163.com

Feng Duan, MD  ·  86 13910984586  ·  duanfeng@vip.sina.com

Always discuss trial participation with your own doctor first.

Locations (2)

Chinese PLA General hospitalBeijing, Beijing Municipality, ChinaRecruiting
Chinese PLA General hospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06624098